Marvin L White is President and CEO of Aptevo Therapeutics Inc.. Currently has a direct ownership of 67,430 shares of APVO, which is worth approximately $324,338. The most recent transaction as insider was on Mar 03, 2024, when has been sold 9,584 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67.4K
0% 3M change
68.0% 12M change
Total Value Held $324,338

Marvin L White Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2024
BUY
Exercise of conversion of derivative security
-
9,584 Added 12.44%
67,430 Common Stock
Mar 02 2024
BUY
Exercise of conversion of derivative security
-
12,917 Added 18.25%
57,846 Common Stock
Jan 28 2024
BUY
Exercise of conversion of derivative security
-
4,792 Added 9.64%
44,929 Common Stock
Mar 03 2023
BUY
Exercise of conversion of derivative security
-
9,582 Added 19.27%
40,137 Common Stock
Jan 29 2023
BUY
Exercise of conversion of derivative security
-
4,791 Added 13.55%
30,555 Common Stock
Jan 29 2022
BUY
Exercise of conversion of derivative security
-
4,792 Added 15.68%
25,764 Common Stock

Also insider at

EBS
Emergent BioSolutions Inc. Healthcare
MLW

Marvin L White

President and CEO
Gaithersburg, MD

Track Institutional and Insider Activities on APVO

Follow Aptevo Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APVO shares.

Notify only if

Insider Trading

Get notified when an Aptevo Therapeutics Inc. insider buys or sells APVO shares.

Notify only if

News

Receive news related to Aptevo Therapeutics Inc.

Track Activities on APVO